EQUITY RESEARCH MEMO

Inkspace Imaging

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)68/100

Inkspace Imaging is a San Francisco-based medical device company that designs and manufactures lightweight, flexible MRI receive coils. Its FDA-cleared coils are compatible with Siemens, GE, and Philips systems, addressing a critical need for improved patient comfort, faster setup times, and enhanced workflow efficiency in MRI imaging. The company's form-fitting technology is tailored for pediatric, adult, and veterinary applications, making it a versatile solution across diverse clinical settings. By bringing imaging closer to the patient, Inkspace aims to reduce scan times and improve diagnostic quality, particularly for challenging populations such as children and patients with limited mobility.

Upcoming Catalysts (preview)

  • Q3 2026FDA clearance for next-generation flexible coil series75% success
  • Q4 2026Strategic partnership with a major MRI OEM for co-marketing or distribution50% success
  • Q2 2026Publication of clinical study demonstrating reduced scan time and improved patient throughput65% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)